Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Revenue

Suzhou Highfine Biotech had revenue of 207.29M CNY in the quarter ending June 30, 2026, with 53.45% growth. This brings the company's revenue in the last twelve months to 711.19M, up 43.06% year-over-year. In the year 2025, Suzhou Highfine Biotech had annual revenue of 602.26M with 33.28% growth.

• Revenue (ttm): 711.19M
• Revenue Growth: +43.06%
• P/S Ratio: 8.58
• Revenue / Employee: 1.05M
• Employees: 678
• Market Cap: 6.10B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	602.26M	150.39M	33.28%
Dec 31, 2024	451.87M	63.08M	16.22%
Dec 31, 2023	388.79M	-58.66M	-13.11%
Jan 1, 2023	447.46M	78.02M	21.12%
Dec 31, 2021	369.44M	87.09M	30.85%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error